Le Lézard
Classified in: Health
Subjects: SVY, PET

Veterinary Endoscopy Market Worth 219.0 Million USD by 2023


PUNE, India, July 5, 2018 /PRNewswire/ --

According to a new market research report "Veterinary Endoscopy Market by Product Type (Flexible, Videoscope, Fibreoptic, Rigid), Procedure (Bronchoscopy, Laparoscopy, Gastroduodenoscopy, Colonoscopy, Rhinoscopy), Animal (Companion, Large), End User (Hospitals, Clinics) - Global Forecast to 2023", published by MarketsandMarketstm, the market is expected to reach USD 219.0 million by 2023 from USD 159.8 million in 2018, at a CAGR of 6.5%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 113 market data Tables and 37 Figures spread through 156 Pages and in-depth TOC on "Veterinary Endoscopy Market"

https://www.marketsandmarkets.com/Market-Reports/veterinary-endoscopy-market-42907480.html

Early buyers will receive 10% customization on this report

The increasing number of pet insurance, growing pet population, rising number of veterinary practitioners and advanced applications of veterinary endoscopes are some of the major factors driving the growth of this market.

By product type, the flexible endoscopes segment is expected to account for the largest share of the market in 2018 

On the basis of product type, this market is classified into rigid endoscopes, flexible endoscopes, and other endoscopes. In 2018, the rigid endoscopes segment is expected to account for the largest share of the Veterinary Endoscopy Market. The large share can be attributed to the increasing requirement of the flexible endoscopes due to their innovative and advanced applications compared to rigid endoscopes.

The companion animals segment is estimated to lead the Veterinary Endoscopy Market in 2018 

By animal type, this market is classified into large animals, companion animals, and other animals. The companion animals segment is expected to account for the largest share of the Veterinary Endoscopy Market in 2018. The large share can be attributed to the increasing awareness about animal health among pet owners and growing companion animal population worldwide.

By end user, the hospitals and academic institutes segment is expected to account for the largest share of the market in 2018 

On the basis of end user, the Veterinary Endoscopy Market is segmented into clinics; and hospitals and academic institutes. The hospitals and academic institutes segment is estimated to account for the largest share of the Veterinary Endoscopy Market in 2018. The large share can be attributed to the increasing number of veterinary procedures performed in hospital-based settings across the world.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=42907480

North America is expected to lead the market in 2018

Based on region, the Veterinary Endoscopy Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018. The large share can be attributed to the rising adoption of companion animals, increasing pet healthcare insurance, and improved veterinary healthcare infrastructure.

Key players in the Veterinary Endoscopy Market include KARL STORZ (Germany), Olympus (Japan), Fujifilm (Japan), Eickemeyer (Germany), B. Braun (Germany), STERIS (UK), Endoscopy Support Services (US), Biovision Veterinary Endoscopy (US), Welch Allyn (US), and Dr. Fritz (Germany).

Know more about the Veterinary Endoscopy Market

https://www.marketsandmarkets.com/Market-Reports/veterinary-endoscopy-market-42907480.html

About MarketsandMarketstm

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]

Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets


These press releases may also interest you

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...



News published on and distributed by: